Summit Investment Advisors »

Cytokinetics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 36k 52.80
2024-06-30 $1.9M 35k 54.18
2024-03-31 $2.2M 31k 70.11
2023-12-31 $783k 9.4k 83.49
2023-09-30 $273k 9.3k 29.46
2023-06-30 $251k 7.7k 32.62
2023-03-31 $227k 6.4k 35.19
2022-12-31 $272k 6.4k 42.20
2022-09-30 $311k 6.4k 48.31
2022-06-30 $241k 6.1k 39.22
2022-03-31 $226k 6.1k 36.78
2021-12-31 $280k 6.1k 45.57
2021-09-30 $220k 6.1k 35.80
2021-06-30 $112k 5.7k 19.81
2021-03-31 $132k 5.7k 23.34
2020-12-31 $118k 5.7k 20.87
2020-09-30 $122k 5.7k 21.57
2020-06-30 $110k 4.7k 23.48
2020-03-31 $55k 4.7k 11.74
2019-12-31 $50k 4.7k 10.67
2019-09-30 $53k 4.7k 11.31
2019-06-30 $53k 4.7k 11.31
2019-03-31 $30k 3.6k 8.23
2018-12-31 $23k 3.6k 6.31
2018-09-30 $36k 3.6k 9.87
2018-06-30 $30k 3.6k 8.23
2018-03-31 $26k 3.6k 7.13
2017-12-31 $30k 3.6k 8.23
2017-09-30 $54k 3.6k 14.81
2017-06-30 $44k 3.6k 12.06
2017-03-31 $36k 2.8k 12.69